Astrana Health Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Astrana Health stock have an average target of 37.29, with a low estimate of 26 and a high estimate of 49. The average target predicts an increase of 46.52% from the current stock price of 25.45.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$26	$37.29	$37	$49
Change	+2.16%	+46.52%	+45.38%	+92.53%

* Price targets were last updated on Feb 2, 2026.

Analyst Ratings

The average analyst rating for Astrana Health stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	5	6	7	7	7	6
Buy	1	1	1	1	1	0
Hold	2	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	9	9	9	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Larsen BTIG	BTIG	Strong Buy Maintains $45 → $40	Strong Buy	Maintains	$45 → $40	+57.17%	Feb 2, 2026
Matthew Shea Needham	Needham	Strong Buy Initiates $28	Strong Buy	Initiates	$28	+10.02%	Dec 12, 2025
Jack Slevin Jefferies	Jefferies	Strong Buy Maintains $44 → $37	Strong Buy	Maintains	$44 → $37	+45.38%	Nov 25, 2025
Andrew Mok Barclays	Barclays	Hold Maintains $36 → $26	Hold	Maintains	$36 → $26	+2.16%	Nov 24, 2025
Ryan Langston TD Cowen	TD Cowen	Strong Buy Maintains $40 → $35	Strong Buy	Maintains	$40 → $35	+37.52%	Nov 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

4.04B

from 3.18B

26.88%

from 3.18B

Revenue Next Year

4.47B

from 4.04B

10.78%

from 4.04B

EPS This Year

1.26

from 0.46

175.42%

from 0.46

EPS Next Year

1.91

from 1.26

51.46%

from 1.26

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	773.92M	1.14B	1.39B	2.03B	3.18B	4.04B	4.47B
Revenue Growth	12.62%	47.84%	21.19%	46.72%	56.39%	26.88%	10.78%
EPS	1.52	0.99	1.29	0.90	0.46	1.26	1.91
EPS Growth	50.50%	-34.87%	30.30%	-30.23%	-49.09%	175.42%	51.46%
Forward PE	-	-	-	-	-	20.17	13.31
No. Analysts	-	-	-	-	-	13	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	4.4B	4.8B
Avg	4.0B	4.5B
Low	3.5B	3.8B

Revenue Growth

Revenue Growth	2026	2027
High	37.6%	19.2%
Avg	26.9%	10.8%
Low	9.8%	-5.6%

EPS Forecast

EPS	2026	2027
High	2.08	2.61
Avg	1.26	1.91
Low	0.03	0.59

EPS Growth

EPS Growth	2026	2027
High	353.7%	107.2%
Avg	175.4%	51.5%
Low	-93.6%	-53.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.